Cowen Downgrades Novartis (NVS) to Market Perform
Tweet Send to a Friend
Cowen analyst Steve Scala downgraded Novartis (NYSE: NVS) from Outperform to Market Perform with a price target of $105.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE